Radiogenomics: a key component of precision cancer medicine.


Journal

British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635

Informations de publication

Date de publication:
09 2023
Historique:
received: 25 10 2022
accepted: 12 06 2023
revised: 02 05 2023
pmc-release: 06 07 2024
medline: 28 8 2023
pubmed: 7 7 2023
entrez: 6 7 2023
Statut: ppublish

Résumé

Radiogenomics, focusing on the relationship between genomics and imaging phenotypes, has been widely applied to address tumour heterogeneity and predict immune responsiveness and progression. It is an inevitable consequence of current trends in precision medicine, as radiogenomics costs less than traditional genetic sequencing and provides access to whole-tumour information rather than limited biopsy specimens. By providing voxel-by-voxel genetic information, radiogenomics can allow tailored therapy targeting a complete, heterogeneous tumour or set of tumours. In addition to quantifying lesion characteristics, radiogenomics can also be used to distinguish benign from malignant entities, as well as patient characteristics, to better stratify patients according to disease risk, thereby enabling more precise imaging and screening. Here, we have characterised the radiogenomic application in precision medicine using a multi-omic approach. we outline the main applications of radiogenomics in diagnosis, treatment planning and evaluations in the field of oncology with the aim of developing quantitative and personalised medicine. Finally, we discuss the challenges in the field of radiogenomics and the scope and clinical applicability of these methods.

Identifiants

pubmed: 37414827
doi: 10.1038/s41416-023-02317-8
pii: 10.1038/s41416-023-02317-8
pmc: PMC10449908
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

741-753

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Front Oncol. 2018 Jun 21;8:228
pubmed: 29977864
J Am Coll Radiol. 2015 Aug;12(8):862-6
pubmed: 26250979
Clin Nucl Med. 2019 Oct;44(10):e548-e558
pubmed: 31306196
Nat Genet. 2016 Apr;48(4):359-66
pubmed: 26901066
Cell Res. 2017 Oct;27(10):1243-1257
pubmed: 28925386
Eur Radiol. 2018 Sep;28(9):3640-3650
pubmed: 29564594
Radiology. 2016 Dec;281(3):907-918
pubmed: 27636026
Cancers (Basel). 2022 Jun 09;14(12):
pubmed: 35740526
Genome Biol. 2019 May 24;20(1):103
pubmed: 31126313
Front Oncol. 2022 Jun 03;12:854979
pubmed: 35719928
Eur Urol. 2014 Jul;66(1):77-84
pubmed: 24613583
Acta Neuropathol. 2016 Jun;131(6):821-31
pubmed: 27040285
J Clin Oncol. 2008 Mar 20;26(9):1419-26
pubmed: 18285604
Cancer Med. 2022 May;11(9):1948-1955
pubmed: 35275444
Comput Methods Programs Biomed. 2017 Mar;140:249-257
pubmed: 28254081
Radiology. 2018 Aug;288(2):407-415
pubmed: 29688159
World J Gastroenterol. 2021 May 7;27(17):2015-2024
pubmed: 34007136
Front Oncol. 2020 Oct 02;10:558162
pubmed: 33117690
J Vasc Interv Radiol. 2007 Jul;18(7):821-31
pubmed: 17609439
Eur Radiol. 2021 Oct;31(10):7374-7385
pubmed: 34374800
Breast Cancer Res Treat. 2008 Nov;112(1):175-87
pubmed: 18075786
Eur Radiol. 2022 May;32(5):3187-3198
pubmed: 35133485
J Clin Oncol. 2011 May 20;29(15):1956-62
pubmed: 21482989
Artif Intell Med. 2022 Aug;130:102331
pubmed: 35809970
Front Pharmacol. 2022 Apr 01;13:862581
pubmed: 35431943
Clin Cancer Res. 2007 Apr 15;13(8):2329-34
pubmed: 17438091
JAMA. 2013 Jun 26;309(24):2563-71
pubmed: 23800934
Cancer Res. 2019 Apr 1;79(7):1696-1704
pubmed: 30760520
Breast Cancer Res. 2021 Jul 17;23(1):74
pubmed: 34274003
Radiology. 2014 Jan;270(1):1-2
pubmed: 24056404
Int J Biol Sci. 2021 Jan 1;17(2):475-486
pubmed: 33613106
Annu Rev Med. 2005;56:303-20
pubmed: 15660514
Mol Cancer. 2017 Feb 16;16(1):41
pubmed: 28209166
Radiology. 2014 Aug;272(2):374-84
pubmed: 24702725
Lancet Oncol. 2016 Aug;17(8):e347-e362
pubmed: 27511159
Gastroenterology. 2011 Sep;141(3):1003-1013.e1-10
pubmed: 21699772
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1435-1445
pubmed: 31811342
Aging (Albany NY). 2021 Mar 26;13(7):9960-9975
pubmed: 33795526
J Immunother Cancer. 2022 Jul;10(7):
pubmed: 35793875
Eur Radiol. 2021 Apr;31(4):2559-2567
pubmed: 33001309
Cancers (Basel). 2022 Aug 22;14(16):
pubmed: 36011048
Radiology. 2016 Aug;280(2):370-8
pubmed: 26937802
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1137-1146
pubmed: 31728587
Front Oncol. 2022 Apr 20;12:780186
pubmed: 35515138
Nature. 2000 Aug 17;406(6797):747-52
pubmed: 10963602
Breast Cancer Res. 2017 Nov 14;19(1):120
pubmed: 29137653
Radiology. 2017 Mar;282(3):665-675
pubmed: 27700229
Front Oncol. 2020 Mar 20;10:369
pubmed: 32266148
J Am Coll Radiol. 2019 Sep;16(9 Pt B):1329-1337
pubmed: 31492411
Can Assoc Radiol J. 2021 Feb;72(1):109-119
pubmed: 32063026
Eur Radiol. 2018 May;28(5):2058-2067
pubmed: 29335867
Radiology. 2020 May;295(2):328-338
pubmed: 32154773
Front Oncol. 2021 Mar 02;11:603882
pubmed: 33738250
Eur Radiol. 2022 Feb;32(2):747-758
pubmed: 34417848
J Hepatol. 2019 Jun;70(6):1133-1144
pubmed: 30876945
Oncol Lett. 2017 Oct;14(4):4135-4141
pubmed: 28943920
Cancers (Basel). 2021 Apr 10;13(8):
pubmed: 33920322
J Immunother Cancer. 2021 Jun;9(6):
pubmed: 34135101
Neuro Oncol. 2020 Mar 5;22(3):402-411
pubmed: 31637430
Mol Imaging Biol. 2020 Apr;22(2):453-461
pubmed: 31209778
Lancet Oncol. 2018 Sep;19(9):1180-1191
pubmed: 30120041
Eur Radiol. 2019 May;29(5):2535-2544
pubmed: 30402704
Acta Oncol. 2014 Jul;53(7):852-64
pubmed: 24666267
Front Oncol. 2019 Mar 27;9:174
pubmed: 30972291
IEEE Trans Med Imaging. 2013 Apr;32(4):637-48
pubmed: 23008246
Eur Radiol. 2019 Aug;29(8):3996-4007
pubmed: 30523454
Radiology. 2018 Jan;286(1):60-70
pubmed: 28885890
Med Phys. 2019 Mar;46(3):1512-1518
pubmed: 30629299
AJR Am J Roentgenol. 2012 Sep;199(3):654-63
pubmed: 22915408
J Magn Reson Imaging. 2018 Feb;47(2):401-409
pubmed: 28640531
Front Oncol. 2020 Feb 28;10:279
pubmed: 32185138
J Magn Reson Imaging. 2019 Mar;49(3):808-817
pubmed: 30194745
Front Oncol. 2020 Nov 05;10:574228
pubmed: 33251138
Cancers (Basel). 2021 Nov 25;13(23):
pubmed: 34885031
Semin Cancer Biol. 2018 Oct;52(Pt 1):56-73
pubmed: 28882552
Eur Radiol. 2016 Aug;26(8):2798-807
pubmed: 26560727
Eur Radiol. 2020 Oct;30(10):5738-5747
pubmed: 32367419
Abdom Imaging. 2015 Oct;40(7):2331-7
pubmed: 25968046
Radiology. 2015 Oct;277(1):114-23
pubmed: 26402495
Front Oncol. 2021 Jul 26;11:679367
pubmed: 34381710
Anticancer Res. 2016 Sep;36(9):4799-804
pubmed: 27630331
Hepatology. 2015 Sep;62(3):792-800
pubmed: 25930992
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Cancers (Basel). 2019 Aug 10;11(8):
pubmed: 31405148
Am J Cancer Res. 2020 Dec 01;10(12):4513-4526
pubmed: 33415015
Eur Radiol. 2020 Apr;30(4):1948-1958
pubmed: 31942672
Eur J Cancer. 2012 Mar;48(4):441-6
pubmed: 22257792
JAMA Netw Open. 2020 Dec 1;3(12):e2030442
pubmed: 33331920
J Magn Reson Imaging. 2015 Nov;42(5):1398-406
pubmed: 25850931
Acad Radiol. 2021 Jul;28(7):e189-e198
pubmed: 32359929
Front Oncol. 2021 Mar 05;11:621088
pubmed: 33747933
Transl Oncol. 2018 Feb;11(1):94-101
pubmed: 29216508
Nat Commun. 2020 Sep 25;11(1):4861
pubmed: 32978398
Front Oncol. 2020 Oct 30;10:1583
pubmed: 33194568
Korean J Radiol. 2021 Jul;22(7):1021-1033
pubmed: 34047501
JAMA. 2019 Jan 22;321(3):288-300
pubmed: 30667505
Neuro Oncol. 2019 Jan 1;21(1):115-124
pubmed: 29846693
J Clin Oncol. 2021 Jan 10;39(2):126-135
pubmed: 33108242
Phys Imaging Radiat Oncol. 2021 Nov 09;20:69-75
pubmed: 34816024
Cancer Cell. 2010 Oct 19;18(4):316-28
pubmed: 20951942
Nat Commun. 2020 Oct 16;11(1):5228
pubmed: 33067442
Cancers (Basel). 2020 May 31;12(6):
pubmed: 32486453
Eur J Radiol. 2019 Apr;113:148-152
pubmed: 30927939
Cancer Discov. 2014 Feb;4(2):155-65
pubmed: 24441285
Sci Rep. 2022 May 24;12(1):8784
pubmed: 35610333
Front Med (Lausanne). 2022 Jun 14;9:886763
pubmed: 35775006
Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1084-1092
pubmed: 26072091
Neuro Oncol. 2021 Feb 25;23(2):304-313
pubmed: 32706862
Invest Radiol. 2021 Aug 1;56(8):501-508
pubmed: 33660629
Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):848-854
pubmed: 30627815
Eur J Cancer. 2021 Jun;150:99-107
pubmed: 33892411
Eur Radiol. 2019 Oct;29(10):5415-5422
pubmed: 30877466
Radiology. 2016 Nov;281(2):382-391
pubmed: 27144536
Radiol Med. 2021 Jun;126(6):786-794
pubmed: 33512651
Oncogene. 2020 Nov;39(45):6906-6919
pubmed: 32978516
Clin Cancer Res. 2018 Mar 1;24(5):1073-1081
pubmed: 29167275
Eur Radiol. 2019 Feb;29(2):877-888
pubmed: 30039219
Clin Nucl Med. 2019 Nov;44(11):905-906
pubmed: 31584495
Neuro Oncol. 2018 May 18;20(6):848-857
pubmed: 29036412
Nat Neurosci. 2018 Apr;21(4):497-505
pubmed: 29507413
J Magn Reson Imaging. 2019 Feb;49(2):518-524
pubmed: 30129697
Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1339-1346
pubmed: 32634544
Cancers (Basel). 2021 Feb 10;13(4):
pubmed: 33578746
Eur Radiol. 2018 Jul;28(7):2960-2968
pubmed: 29404769
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Int J Mol Sci. 2020 Oct 27;21(21):
pubmed: 33121211
AJR Am J Roentgenol. 2011 Oct;197(4):990-7
pubmed: 21940590
Eur J Nucl Med Mol Imaging. 2018 May;45(5):735-750
pubmed: 29164298
Radiology. 2014 Nov;273(2):365-72
pubmed: 25028781
J Clin Oncol. 2007 Feb 10;25(5):587-95
pubmed: 17290067
J Natl Cancer Inst. 2020 Feb 1;112(2):179-190
pubmed: 31095341
Nature. 2013 Sep 19;501(7467):328-37
pubmed: 24048065
Comput Biol Med. 2019 Jun;109:218-225
pubmed: 31078126
Nat Rev Clin Oncol. 2017 Dec;14(12):749-762
pubmed: 28975929
Neuro Oncol. 2017 Jan;19(1):109-117
pubmed: 27353503
J Digit Imaging. 2019 Apr;32(2):276-282
pubmed: 30706213

Auteurs

Zaoqu Liu (Z)

Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, Henan, China.
Interventional Institute of Zhengzhou University, 450052, Zhengzhou, Henan, China.
Interventional Treatment and Clinical Research Center of Henan Province, 450052, Zhengzhou, Henan, China.

Tian Duan (T)

Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, Henan, China.

Yuyuan Zhang (Y)

Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, Henan, China.

Siyuan Weng (S)

Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, Henan, China.

Hui Xu (H)

Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, Henan, China.

Yuqing Ren (Y)

Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, Henan, China.

Zhenyu Zhang (Z)

Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, Henan, China. fcczhangzy1@zzu.edu.cn.

Xinwei Han (X)

Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, Henan, China. fcchanxw@zzu.edu.cn.
Interventional Institute of Zhengzhou University, 450052, Zhengzhou, Henan, China. fcchanxw@zzu.edu.cn.
Interventional Treatment and Clinical Research Center of Henan Province, 450052, Zhengzhou, Henan, China. fcchanxw@zzu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH